Re: Darolutamide and Survival in Metastatic, Hormone-sensitive Prostate Cancer
Details
Publication Year 2022-07,Volume 82,Issue #1,Page 146-147
Journal Title
European Urology
Publication Type
Commentary
Keywords
Androgen Receptor Antagonists; Hormones; Humans; Male; *Prostatic Neoplasms/drug therapy; *Prostatic Neoplasms, Castration-Resistant/pathology; Pyrazoles
Department(s)
Surgical Oncology; Medical Oncology
PubMed ID
35346516
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-10-16 03:58:18
Last Modified: 2024-10-16 03:59:23

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙